Investigation of the role of LRP in multidrug resistance

作者: Daragh Byrne

DOI:

关键词:

摘要: There have been many reports linking the overexpression of lung resistance-related protein (LRP) with cross-resistance to chemotherapeutic drugs. However, no conclusive evidence existed link LRP a direct role in multidrug resistance (LRP). The OAW42SR is cell line derived from serous adenocarcinoma ovaries, and displays an increase cytotoxic drugs concomitant moderate expression. Anti- ribozyme antisense expression plasmids were employed this study order inhibit examine any resulting effect on drug cells. Antisense oligonucleotides also used decrease provide clearer picture whether involved MDR. A large number clones isolated after transfection anti- plasmids. These displayed varying levels at both mRNA level. Cells transfected only control vector decreases expression, highlighting extent clonal variation within population. anti-LRP construct appeared significantly reduce RNA failed levels, but dramatically reduced This demonstrated that acts mainly through steric inhibition processing rather than cleavage target RNA, as ribozymes. Resistance anthracyclines Vinca alkaloids was clones. could not be correlated reduction tested MDR facilitators, gene 1 (mdr-1) resistance-associated (MRP), largely invariant, directly observed reductions resistance. profiles were, however, strikingly similar typical mdr-1 overexpressing lines. It cannot ruled out, therefore, Pglycoprotein activity, due post-translational modifications, may sole mechanism these targeted LRP, level cells, induce adriamycin. thesis provides first resistance, last line.

参考文章(198)
AM Tari, SD Tucker, A Deisseroth, G Lopez-Berestein, Liposomal Delivery of Methylphosphonate Antisense Oligodeoxynucleotides in Chronic Myelogenous Leukemia Blood. ,vol. 84, pp. 601- 607 ,(1994) , 10.1182/BLOOD.V84.2.601.601
Daragh Byrne, Carmel Daly, Martin Clynes, Antisense Methods in Cell Culture Springer Berlin Heidelberg. pp. 545- 554 ,(1998) , 10.1007/978-3-642-80412-0_29
Alfredo Berzal‐Herranz, Simpson Joseph, Bharat M Chowrira, Samuel E Butcher, JM Burke, Essential nucleotide sequences and secondary structure elements of the hairpin ribozyme. The EMBO Journal. ,vol. 12, pp. 2567- 2573 ,(1993) , 10.1002/J.1460-2075.1993.TB05912.X
T. Sumizawa, S.-I. Akiyama, Z.-S. Chen, T. Furukawa, Resistance to cisplatin. Anti-cancer Drug Design. ,vol. 14, pp. 143- 151 ,(1999)
Ming Tan, Mien Chie Hung, Dihua Yu, Bolin Liu, Shan Shue Wang, Junzhi Li, Overexpression of c-erbB-2/neu in breast cancer cells confers increased resistance to Taxol via mdr-1-independent mechanisms. Oncogene. ,vol. 13, pp. 1359- 1365 ,(1996)
Scheper Rj, Meijer Cj, Izquierdo Ma, van der Valk P, Broxterman Hj, Flens Mj, Giaccone G, Scheffer Gl, Broad distribution of the multidrug resistance-related vault lung resistance protein in normal human tissues and tumors. American Journal of Pathology. ,vol. 148, pp. 877- 887 ,(1996)
G. Paolella, B.S. Sproat, A.I. Lamond, Nuclease resistant ribozymes with high catalytic activity. The EMBO Journal. ,vol. 11, pp. 1913- 1919 ,(1992) , 10.1002/J.1460-2075.1992.TB05244.X
Miguel A. Izquierdo, George L. Scheffer, Anouk B. Schroeijers, Mariska C. de Jong, Rik J. Scheper, Vault-related resistance to anticancer drugs determined by the expression of the major vault protein LRP Cytotechnology. ,vol. 27, pp. 137- 148 ,(1998) , 10.1023/A:1008004502861
Sidney Altman, Ribonuclease P: An Enzyme with a Catalytic RNA Subunit Advances in Enzymology - and Related Areas of Molecular Biology. ,vol. 62, pp. 1- 36 ,(1989) , 10.1002/9780470123089.CH1